Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

The FDA has approved Spravato (esketamine) nasal spray for use as monotherapy for patients with treatment-resistant depression.

Prompted by Blue Monday, the BBC's special correspondent reflects on his struggle to find balance and joy in life - and a ...

A pioneering NHS trial is set to explore the potential of a brain-computer interface (BCI) that uses ultrasound to alter ...

A international joint research team of KAIST and the University of Michigan developed a digital biomarker for predicting ...

The CORONA virus pandemic also brought about a pandemic of mental illness. Approximately one billion people worldwide suffer from various psychiatric conditions. Korea is one of more serious cases, ...

A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the ...

Barking, Havering and Redbridge University Hospitals NHS Trust will trial a whole-brain computer interface to modulate ...

Similarly, vagus nerve stimulation (VNS), used for treatment-resistant depression under some circumstances, involves a surgically implanted device that sends impulses through the left vagus nerve ...

Severe depression could be treated by the groundbreaking treatment technique ... They were implanted with a pacemaker-like device, under the skin in the chest that stimulated their left vagus ...